Skip to main content
Relay Therapeutics, Inc. (RLAY)
NASDAQ: RLAY · Real-Time Price · USD
10.14
+0.25 (2.53%)
At close: Mar 9, 2026, 4:00 PM EDT
9.70
-0.44 (-4.34%)
After-hours: Mar 9, 2026, 5:22 PM EDT

Relay Therapeutics Revenue

In the year 2025, Relay Therapeutics had annual revenue of $15.36M with 53.44% growth. Relay Therapeutics had revenue of $7.00M in the quarter ending December 31, 2025.

Revenue (ttm)
$15.36M
Revenue Growth
+53.44%
P/S Ratio
116.40
Revenue / Employee
$79,974
Employees
192
Market Cap
1.81B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202515.36M5.35M53.44%
Dec 31, 202410.01M-15.54M-60.83%
Dec 31, 202325.55M24.17M1,749.82%
Dec 31, 20221.38M-1.65M-54.41%
Dec 31, 20213.03M-79.63M-96.34%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

RLAY News

More News